NEW YORK (360Dx) – Massachusetts Institute of Technology spinout Glympse Bio today announced it has raised $22 million in a Series A financing round.

Venture Capital firms LS Polaris Innovation Fund and ARCH Ventures led the round and were joined by new investors Charles River Ventures, Gilead Sciences, Yonghua Capital, and Inevitable Ventures. Existing investors GreatPoint Ventures, Heritage Provider Network, and Rivas Capital also participated.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.